TABLE 1.
Characteristic | Participants included (n = 34) | Participants not included (n = 72) | P |
---|---|---|---|
Age, y2 | 46.8 ± 11.2 | 47.0 ± 12.3 | 0.93 |
Female, n (%)2 | 23 (67.7) | 58 (80.6) | 0.14 |
Race/ethnicity (self-identified), n (%) | |||
Non-Hispanic White | 6 (17.7) | 13 (18.1) | 0.74 |
African American | 19 (55.9) | 39 (54.2) | |
Asian/Pacific Islander | 0 (0.0) | 2 (2.8) | |
Hispanic | 6 (17.7) | 15 (20.8) | |
Other (e.g., decline to state, multirace) | 3 (8.8) | 3 (4.2) | |
Education, n (%) | |||
High school/GED or less | 5 (14.7) | 9 (12.5) | 0.78 |
College - 1 y – 3 y | 13 (38.2) | 30 (41.7) | |
College - 4 y or more | 11 (32.4) | 18 (25.0) | |
Postcollege | 5 (14.7) | 15 (20.8) | |
Income, n (%) | |||
<$35,000 | 13 (38.2) | 21 (29.2) | 0.36 |
$35,000 to <$55,000 | 8 (23.5) | 18 (25.0) | |
$55,000 to <$75,000 | 2 (5.9) | 13 (18.1) | |
≥$75,000 | 11 (32.4) | 20 (27.8) | |
BMI, kg/m2 | 36.6 ± 6.2 | 37.3 ± 6.0 | 0.57 |
Weight, kg | 101.3 ± 13.3 | 101.6 ± 16.1 | 0.93 |
Waist circumference, cm | 111.8 ± 12.7 | 113.2 ± 12.6 | 0.61 |
PHQ-9 score | 12.3 ± 2.3 | 13.1 ± 3.0 | 0.14 |
10–14 (moderate depression), n (%) | 30 (88.0) | 51 (70.8) | 0.13 |
15–19 (moderately severe depression), n (%) | 3 (8.8) | 18 (25.0) | |
≥20 (severe depression), n (%) | 1 (2.9) | 3 (4.2) | |
SCL-20 score | 1.0 ± 0.7 | 1.3 ± 0.6 | 0.013 |
GAD-7 score | 5.0 ± 4.0 | 7.9 ± 4.9 | 0.0043 |
0–4 (minimal anxiety), n (%) | 15 (44.1) | 28 (38.9) | 0.08 |
5–9 (mild anxiety), n (%) | 15 (44.1) | 19 (26.4) | |
10–14 (moderate anxiety), n (%) | 3 (8.8) | 20 (27.8) | |
15–21 (severe anxiety), n (%) | 1 (2.9) | 5 (6.9) | |
Current use of ADM, n (%) | 2 (5.9) | 17 (23.6) | 0.033 |
SBP, mmHg | 124.2 ± 17.9 | 121.8 ± 16.4 | 0.49 |
DBP, mmHg | 78.9 ± 14.4 | 76.2 ± 8.9 | 0.31 |
DASH score | 1.6 ± 0.9 | 1.6 ± 1 | 0.95 |
Intake of fruit and vegetable, servings/d | 2.5 ± 2.0 | 3.1 ± 1.9 | 0.13 |
Total fat, g/d | 67.6 ± 20.5 | 73.4 ± 34.7 | 0.28 |
Energy intake, kilocalories/d | 1658.0 ± 550.9 | 1721.8 ± 720.1 | 0.65 |
ADM, antidepressant medication; DBP, diastolic blood pressure; GAD-7, Generalized Anxiety Disorder 7-Item Scale; GED, general educational development; P, P value; PHQ-9, Patient Health Questionnaire-9; SBP, systolic blood pressure; SCL-20, Depression Symptom Checklist-20.
Values are mean ± SD unless noted otherwise.
Prognostic factors for randomization: age, sex, and treatment group.
Indicate P values <0.05.